68Ga-Pentixafor Positron Emission Tomography/Computed Tomography in Primary Aldosteronism: Preliminary Analysis on Contrast-Enhanced Computed Tomography Concordance and Positron Emission Tomography/Computed Tomography Avidity Patterns
Hormone and Metabolic Research · 01.09.2025 · 57 (09) · 499-504
DOI: 10.1055/a-2700-7598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.09.2025. Verfasst von Anuj Ban und 11 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, India. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Hyperaldosteronism, Contrast Media, Coordination Complexes. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
68Ga-Pentixafor positron emission tomography/computed tomography has shown potential in primary aldosteronism subtyping, but analysis of its diagnostic accuracy based on contrast-enhanced computed tomography concordance and positron emission tomography/computed tomography avidity patterns is lacking. The objective of this study was to evaluate the diagnostic accuracy of 68Ga-Pentixafor positron emission tomography/computed tomography for subtyping primary aldosteronism and to assess its performance based on concordance with contrast-enhanced computed tomography and positron emission tomography/computed tomography avidity patterns. Clinical, biochemical, radiological, functional imaging, treatment, histopathological, and follow-up details of 30 patients with primary aldosteronism who underwent positron emission tomography/computed tomography over 2 years at a tertiary center in India were retrospectively analyzed. Diagnostic accuracy of positron emission tomography/computed tomography for primary aldosteronism subtyping was evaluated in the whole cohort and in subgroups based on contrast-enhanced computed tomography–positron emission tomography/computed tomography concordance and positron emission tomography/computed tomography avidity patterns. Out of the 30 patients, final subtype classification was achieved in 15 (9 unilateral and 6 bilateral) based on surgical outcomes and/or adrenal venous sampling. Positron emission tomography/computed tomography correctly subtyped 14/15 (93.3%) patients. Contrast-enhanced computed tomography and positron emission tomography/computed tomography concordance was seen in 10 patients, and positron emission tomography/computed tomography accuracy was 100% (10/10) in this subgroup. Contrast-enhanced computed tomography and positron emission tomography/computed tomography discordance (contrast-enhanced computed tomography bilateral and positron emission tomography/computed tomography unilateral) was seen in five patients, and positron emission tomography/computed tomography accuracy in this subgroup was 80% (4/5). Positron emission tomography/computed tomography avidity patterns in the 15 patients having final subtype classification were unilateral avid (n=10), bilateral avid (n=2), and bilateral nonavid (n=3). Diagnostic accuracy of positron emission tomography/computed tomography was 90% (9/10) in patients with unilateral avidity, and 100% in those with bilateral avidity or nonavidity. Preliminary analysis suggests that positron emission tomography/computed tomography demonstrates higher accuracy in certain subgroups, potentially guiding the triage for adrenal venous sampling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endocrinology, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, India.
- Endocrinology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, India.
- Nuclear Medicine, Homi Bhabha National Institute, Mumbai, India.
- Radiology, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, India.
- General Surgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, India.
- Endocrinology, Sakra World Hospital, Bengaluru, India.
Zitieren
APA
Ban, A., Lila, A. R., Karlekar, M., Barnabas, R., Memon, S. S., Sarathi, V., Malhotra, G., Rathod, K., Rege, S., Badhe, P., Harinarayan, C. V., & Bandgar, T. (2025). 68Ga-Pentixafor Positron Emission Tomography/Computed Tomography in Primary Aldosteronism: Preliminary Analysis on Contrast-Enhanced Computed Tomography Concordance and Positron Emission Tomography/Computed Tomography Avidity Patterns. Hormone and Metabolic Research, 57(09), 499-504. https://doi.org/10.1055/a-2700-7598
Vancouver
Ban A, Lila AR, Karlekar M, Barnabas R, Memon SS, Sarathi V, et al. 68Ga-Pentixafor Positron Emission Tomography/Computed Tomography in Primary Aldosteronism: Preliminary Analysis on Contrast-Enhanced Computed Tomography Concordance and Positron Emission Tomography/Computed Tomography Avidity Patterns. Hormone and Metabolic Research. 2025;57(09):499-504. doi:10.1055/a-2700-7598
BibTeX
@article{Ban2025,
author = {Ban, Anuj and Lila, Anurag Ranjan and Karlekar, Manjiri and Barnabas, Rohit and Memon, Saba Samad and Sarathi, Vijaya and Malhotra, Gaurav and Rathod, Krantikumar and Rege, Sameer and Badhe, Padma and Harinarayan, C V and Bandgar, Tushar},
title = {68Ga-Pentixafor Positron Emission Tomography/Computed Tomography in Primary Aldosteronism: Preliminary Analysis on Contrast-Enhanced Computed Tomography Concordance and Positron Emission Tomography/Computed Tomography Avidity Patterns},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {09},
pages = {499--504},
doi = {10.1055/a-2700-7598}
}
EUVIMED